The Effects of Chromium Supplementation on Gene Expression of Insulin, Lipid, and Inflammatory Markers in Infertile Women With Polycystic Ovary Syndrome Candidate for in vitro Fertilization: A Randomized, Double-Blinded, Placebo-Controlled Trial

Frontiers in Endocrinology

Volumn 9, Issue , 2018, Pages

  Amiri Siavashani, Mehrnush ^a   Zadeh Modarres, Shahrzad ^b   Mirhosseini, Naghmeh ^c   Aghadavod, Esmat ^d   Salehpour, Saghar ^a   Asemi, Zatollah ^d  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

chromium supplementation; gene expression; inflammatory markers; insulin metabolism; polycystic ovary syndrome

Indexed keywords

EID: 85087388549     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2018.00726     Document Type: Article

References (35)

1. Yildiz BO Bozdag G Yapici Z Esinler I Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. (2012) 27:3067–73. 10.1093/humrep/des23222777527
2. Amato G Conte M Mazziotti G Lalli E Vitolo G Tucker AT et al. Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles. Obstet Gynecol. (2003) 101:1177–82.12798522
3. Valckx SD Arias-Alvarez M De Pauw I Fievez V Vlaeminck B Fransen E et al. Fatty acid composition of the follicular fluid of normal weight, overweight and obese women undergoing assisted reproductive treatment: a descriptive cross-sectional study. Reprod Biol Endocrinol. (2014) 12:13. 10.1186/1477-7827-12-1324498875
4. Valckx SD De Pauw I De Neubourg D Inion I Berth M Fransen E et al. BMI-related metabolic composition of the follicular fluid of women undergoing assisted reproductive treatment and the consequences for oocyte and embryo quality. Hum Reprod. (2012) 27:3531–9. 10.1093/humrep/des35023019302
5. An LF Zhang XH Sun XT Zhao LH Li S Wang WH. Unexplained infertility patients have increased serum IL-2, IL-4, IL-6, IL-8, IL-21, TNFalpha, IFNgamma and increased Tfh/CD4 T cell ratio: increased Tfh and IL-21 strongly correlate with presence of autoantibodies. Immunol Invest. (2015) 44:164–73. 10.3109/08820139.2014.93237725032981
6. Ozkan ZS Deveci D Kumbak B Simsek M Ilhan F Sekercioglu S et al. What is he impact of Th1/Th2 ratio, SOCS3, IL17, and IL35 levels in unexplained infertility? J Reprod Immunol. (2014) 103:53–8. 10.1016/j.jri.2013.11.002
7. Letterio JJ Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol. (1998) 16:137–619597127
8. Fornari MC Sarto A Berardi VE Martinez MA Rocha MG Pasqualini S et al. Effect of ovaric hyper-stimulation on blood lymphocyte subpopulations, cytokines, leptin and nitrite among patients with unexplained infertility. Am J Reprod Immunol. (2002) 48:394–403.12607776
9. Fazelian S Rouhani MH Bank SS Amani R. Chromium supplementation and polycystic ovary syndrome: a systematic review and meta-analysis. J Trace Elem Med Biol. (2017) 42:92–6. 10.1016/j.jtemb.2017.04.00828595797
10. Jamilian M Zadeh Modarres S Amiri Siavashani M Karimi M Mafi A Ostadmohammadi V et al. The influences of chromium supplementation on glycemic control, markers of cardio-metabolic risk, and oxidative stress in infertile polycystic ovary syndrome women candidate for in vitro fertilization: a randomized, double-blind, placebo-controlled trial. Biol Trace Elem Res. (2018):48–55. 10.1007/s12011-017-1236-329307112
11. Sahin K Tuzcu M Orhan C Sahin N Kucuk O Ozercan IH et al. Anti-diabetic activity of chromium picolinate and biotin in rats with type 2 diabetes induced by high-fat diet and streptozotocin. Br J Nutr. (2013) 110:197–205. 10.1017/S000711451200485023211098
12. Wang ZQ Zhang XH Russell JC Hulver M Cefalu WT. Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats. J Nutr. (2006) 136:415–20. 10.1093/jn/136.2.41516424121
13. Jain SK Rains JL Croad JL. Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radic Biol Med. (2007) 43:1124–31. 10.1016/j.freeradbiomed.2007.05.01917854708
14. Martino F Puddu PE Pannarale G Colantoni C Martino E Niglio T et al. Low dose chromium-polynicotinate or policosanol is effective in hypercholesterolemic children only in combination with glucomannan. Atherosclerosis. (2013) 228:198–202. 10.1016/j.atherosclerosis.2013.02.00523453352
15. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. (2004) 81:19–25.
16. Tatsch E Bochi GV Pereira Rda S Kober H Agertt VA de Campos MM et al. A simple and inexpensive automated technique for measurement of serum nitrite/nitrate. Clin Biochem. (2011) 44:348–50. 10.1016/j.clinbiochem.2010.12.01121185277
17. Dunkley PR Jarvie PE Robinson PJ. A rapid Percoll gradient procedure for preparation of synaptosomes. Nat Protoc. (2008) 3:1718–28. 10.1038/nprot.2008.17118927557
18. Jamilian M Bahmani F Siavashani MA Mazloomi M Asemi Z Esmaillzadeh A. The Effects of chromium supplementation on endocrine profiles, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Biol Trace Elem Res. (2016) 172:72–8. 10.1007/s12011-015-0570-626613790
19. Asemi Z Foroozanfard F Hashemi T Bahmani F Jamilian M Esmaillzadeh A. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Clin Nutr. (2015) 34:586–92. 10.1016/j.clnu.2014.09.01525300649
20. Foroozanfard F Jamilian M Bahmani F Talaee R Talaee N Hashemi T et al. Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Clin Endocrinol. (2015) 83:888–94. 10.1111/cen.1284026119844
21. Chen G Liu P Pattar GR Tackett L Bhonagiri P Strawbridge AB et al. Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Mol Endocrinol. (2006) 20:857–70. 10.1210/me.2005-025516339278
22. Ulas M Orhan C Tuzcu M Ozercan IH Sahin N Gencoglu H et al. Anti-diabetic potential of chromium histidinate in diabetic retinopathy rats. BMC Complement Altern Med. (2015) 15:16. 10.1186/s12906-015-0537-325652875
23. Arvind K Pradeepa R Deepa R Mohan V. Diabetes & coronary artery disease. Indian J Med Res. (2002)116:163–7612710546
24. Benigni A Zoja C Campana M Corna D Sangalli F Rottoli D et al. Beneficial effect of TGFbeta antagonism in treating diabetic nephropathy depends on when treatment is started. Nephron Exp Nephrol. (2006) 104:e158–68. 10.1159/00009496716902320
25. Bobulescu IA. Renal lipid metabolism and lipotoxicity. Curr Opin Nephrol Hypertens. (2010) 19:393–402. 10.1097/MNH.0b013e32833aa4ac20489613
26. Jain SK Croad JL Velusamy T Rains JL Bull R. Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFkappaB, Akt, and Glut-2 in livers of zucker diabetic fatty rats. Mol Nutr Food Res. (2010) 54:1371–80. 10.1002/mnfr.20090017720306473
27. Sahin N Akdemir F Orhan C Aslan A Agca CA Gencoglu H et al. A novel nutritional supplement containing chromium picolinate, phosphatidylserine, docosahexaenoic acid, and boron activates the antioxidant pathway Nrf2/HO-1 and protects the brain against oxidative stress in high-fat-fed rats. Nutr Neurosci. (2012) 15:42–7. 10.1179/1476830512Y.000000001823232054
28. Donnelly R Davis KR. Type 2 diabetes and atherosclerosis. Diabetes Obes Metab. (2000) 2 (Suppl. 1):S21–30.11225756
29. Evans JL Maddux BA Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal. (2005) 7:1040–52. 10.1089/ars.2005.7.104015998259
30. Bartlett HE Eperjesi F. Nutritional supplementation for type 2 diabetes: a systematic review. Ophthalmic Physiol Opt. (2008) 28:503–23. 10.1111/j.1475-1313.2008.00595.x19076553
31. Haimovici F Anderson JL Bates GW Racowsky C Ginsburg ES Simovici D et al. Stress, anxiety, and depression of both partners in infertile couples are associated with cytokine levels and adverse IVF outcome. Am J Reprod Immunol. (2018) 79:e12832. 10.1111/aji.1283229528174
32. Wang XF Xing FQ Chen SL. Interleukin-1beta expression on ovarian granulosa cells and its clinical implication in women undergoing in vitro fertilization. Di Yi Jun Yi Da Xue Xue Bao. (2002) 22:934–6.12377625
33. Wunder DM Mueller MD Birkhauser MH Bersinger NA. Increased ENA-78 in the follicular fluid of patients with endometriosis. Acta Obstet Gynecol Scand. (2006) 85:336–42. 10.1080/0001634050050171516553183
34. Levin I Gamzu R Mashiach R Lessing JB Amit A Almog B. Higher C-reactive protein levels during IVF stimulation are associated with ART failure. J Reprod Immunol. (2007) 75:141–44. 10.1016/j.jri.2007.03.00417466381
35. Winger EE Reed JL Ashoush S Ahuja S El-Toukhy T Taranissi M. Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am J Reprod Immunol. (2009) 61:113–20. 10.1111/j.1600-0897.2008.00669.x19055656